CASE STUDY
Scaling up a new process to create synthetic DNA
CPI helped Touchlight to scale-up their cell-free dbDNA process, grow their business and secure £147m private investment.
6 February 2023
CASE STUDY
The UK’s vaccine programme has been vital in combatting COVID-19. In April 2020, CPI joined the UK Government’s Vaccine Taskforce to support the manufacture and formulation of novel mRNA vaccine candidates in the fight against the virus.
3 February 2022
CASE STUDY
Attracting global firms to Renfrewshire
Forging new relationships with both industrial leaders and local communities alike, HVM Catapult’s presence in Renfrewshire is bringing tangible benefits to the region and Scotland as a whole.
3 February 2022